BI Asset Management Fondsmaeglerselskab A S Sells 40,871 Shares of The Allstate Corporation $ALL

BI Asset Management Fondsmaeglerselskab A S trimmed its holdings in shares of The Allstate Corporation (NYSE:ALLFree Report) by 74.5% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,008 shares of the insurance provider’s stock after selling 40,871 shares during the quarter. BI Asset Management Fondsmaeglerselskab A S’s holdings in Allstate were worth $2,901,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Rehmann Capital Advisory Group lifted its stake in shares of Allstate by 3.2% during the 1st quarter. Rehmann Capital Advisory Group now owns 1,630 shares of the insurance provider’s stock worth $338,000 after purchasing an additional 51 shares during the last quarter. Vantage Point Financial LLC raised its holdings in Allstate by 3.6% in the first quarter. Vantage Point Financial LLC now owns 1,495 shares of the insurance provider’s stock worth $310,000 after purchasing an additional 52 shares in the last quarter. Confluence Wealth Services Inc. lifted its position in shares of Allstate by 0.7% during the first quarter. Confluence Wealth Services Inc. now owns 8,000 shares of the insurance provider’s stock valued at $1,558,000 after buying an additional 54 shares during the last quarter. Linscomb Wealth Inc. lifted its position in shares of Allstate by 1.3% during the first quarter. Linscomb Wealth Inc. now owns 4,079 shares of the insurance provider’s stock valued at $845,000 after buying an additional 54 shares during the last quarter. Finally, Achmea Investment Management B.V. boosted its holdings in shares of Allstate by 0.3% in the 1st quarter. Achmea Investment Management B.V. now owns 20,586 shares of the insurance provider’s stock valued at $4,262,000 after buying an additional 57 shares in the last quarter. Hedge funds and other institutional investors own 76.47% of the company’s stock.

Allstate Stock Up 1.5%

Shares of ALL stock opened at $213.4930 on Thursday. The Allstate Corporation has a fifty-two week low of $176.00 and a fifty-two week high of $214.76. The firm has a market capitalization of $56.26 billion, a PE ratio of 10.04, a P/E/G ratio of 0.86 and a beta of 0.35. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.43 and a current ratio of 0.43. The stock’s 50-day simple moving average is $198.91 and its 200-day simple moving average is $198.81.

Allstate (NYSE:ALLGet Free Report) last announced its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $5.94 EPS for the quarter, beating the consensus estimate of $3.20 by $2.74. Allstate had a net margin of 8.79% and a return on equity of 28.74%. The business had revenue of $15.05 billion during the quarter, compared to analysts’ expectations of $16.59 billion. During the same period in the previous year, the business posted $1.61 EPS. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. Equities analysts expect that The Allstate Corporation will post 18.74 earnings per share for the current year.

Allstate Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 1st. Shareholders of record on Friday, August 29th will be issued a dividend of $1.00 per share. This represents a $4.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend is Friday, August 29th. Allstate’s dividend payout ratio (DPR) is presently 18.81%.

Wall Street Analysts Forecast Growth

Several research firms recently commented on ALL. Keefe, Bruyette & Woods boosted their price objective on shares of Allstate from $237.00 to $246.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 6th. UBS Group upped their price target on Allstate from $230.00 to $235.00 and gave the stock a “buy” rating in a research report on Wednesday, July 9th. Wall Street Zen raised Allstate from a “hold” rating to a “buy” rating in a research report on Tuesday, August 5th. Evercore ISI upped their target price on Allstate from $227.00 to $230.00 and gave the company an “outperform” rating in a research report on Thursday, May 1st. Finally, Wells Fargo & Company set a $202.00 price target on Allstate and gave the company an “equal weight” rating in a research note on Tuesday, August 5th. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Allstate presently has an average rating of “Moderate Buy” and a consensus target price of $230.73.

Get Our Latest Stock Analysis on ALL

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Featured Articles

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALLFree Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.